Abstract:Objective: Neuroendocrine neoplasms (NENs) are relatively rare and heterogeneous malignancies with two major subtypes: low-grade neuroendocrine tumor (NET) and high-grade neuroendocrine carcinoma (NEC). Comprehensive molecular characterization of NENs is needed to refine our understanding of the biological underpinnings of different NEN subtypes and to predict disease progression more accurately. Methods: We performed whole-exome sequencing (WES) of NEN samples from 49 patients (25 NETs and 24 NECs) arising from the stomach, intestines or lung. Clinicopathologic features were assessed and associated with molecular events. Results: NENs generally harbor a low mutation burden, with TP53 being the top mutated gene found in 31% of patients. Consistent with other studies, p53 signaling pathway dysfunction is significantly enriched in NECs compared to NETs (P<0.01). Other than TP53, tissue type-specific mutation profiles of NENs were observed in our cohort compared to those reported in pancreatic NETs. Importantly, we observed significant genomic instability, with increased copy number alterations observed across the NEN genome, which was more profound in NECs and independently correlated with poor overall survival (OS) (P<0.001). NECs could be further stratified into two molecular subtypes based on OS (P<0.001) and the chromosomal instability score (CIS). Interestingly, we discovered that the gain of whole chromosome 5 occurred at the early stage of NEN development, followed by the loss of 5q exclusively in NECs (P<0.001). Conclusions: These findings provide novel insights into the molecular characteristics of NENs and highlight the association of genomic stability with clinical outcomes.

The presentation of 14th annual European neuroendocrine tumor society conference

Advances and Pathological Diagnostic Standard of Gastroenteropancreatic Neuroendocrine Neoplasms

Renewal of ideas and focus of gastroenteropancreatic neuroendocrine neoplasm

2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Pathologic research update of colorectal neuroendocrine tumors.

Reflections on hot issues of pancreatic neuroendocrine neoplasms

Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendo-crine tumor

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

The Latest Exploration of Staging and Prognostic Classification for Pancreatic Neuroendocrine Tumors: a Large Population-Based Study

Recent Research Hotspots in Sequencing and the Pancreatic Neuroendocrine Tumor Microenvironment.

Imaging and Future Frontiers

An Illustrated Review of the Recent 2019 World Health Organization Classification of Neuroendocrine Neoplasms: A Radiologic and Pathologic Correlation

Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches

Genomic Dissection of Gastrointestinal and Lung Neuroendocrine Neoplasm.

Whole-Genome Landscape of Pancreatic Neuroendocrine Tumours

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

Clinicopathological Features and Prognostic Validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th Staging Systems in Colonic Neuroendocrine Neoplasms

Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications

Diagnosis and Treatment of Gastrointestinal Neuroendocrine Neoplasm in the Multidisciplinary Team Model

Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach